Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction;Evaluación en el tercer año de implantación del cribado neonatal universal de anemia falciforme en la Comunidad de Madrid

Anales de Pediatria

Volumn 66, Issue 4, 2007, Pages 382-386

  Cela De Julian E ^a   Dulin Iniguez E ^a   Guerrero Soler, M ^a   Arranz Leirado, M ^b   Galaron Garcia P ^a   Belendez Bieler C ^a   Bellon Cano J Ma ^a   Garcia Arias M ^c   Cantalejo Lopez A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Servicio de Sanidad Ambiental Instituto de Salud Pública   (Spain)

^c Equipo Atencion Primaria Rafael A   (Spain)

Author keywords

Hemoglobinopathies; Newborn screening; Sickle cell disease

Indexed keywords

HEMOGLOBIN;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; HEALTH PROGRAM; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PRENATAL DIAGNOSIS; SICKLE CELL ANEMIA; SPAIN; VACCINATION;

EID: 34249333483     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101243     Document Type: Article

References (24)

1. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: A systematic review with supplementary research. Health Technology Assessment. 2000;4:1-99.
2. Shafer FE, Lorey F, Cunningham GC, Klumpp CMS, Vichisnky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncology. 1996;18:36-41.
3. Newborn screening for sickle cell disease and other haemoglobinopathies. Consensus conference. JAMA. 1987;258:1205-9.
4. Leiken SL, Gallagher D, Kinney TR. Mortality in children and adolescents with sickle cell disease. Pediatrics. 1989;84:500-8.
5. Rodgers DW, Clarke JM, Cupidore L. Early deaths in Jamaican children with sickle cell disease. BMJ. 1978;1:1515-6.
6. Vichinsky E, Hurst D, Earles A. Newborn screening for sickle cell disease: Effect on mortality. Pediatrics. 1988;81:749-55.
7. Lees CM, Davies S, Dezateux C. Neonatal screening for sickle cell disease. Cochrane database of Systematic Reviews 2003;3.
8. Henthorn JS. Neonatal screening for sickle cell disorders. British J Haematology. 2004;24:259-63.
9. Gaston MH, Verter JI, Woods G. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med. 1986;314:1593-9.
10. Cantalejo MA, Cela ME, Cervera A, Contra T, Donat J, Estella J, et al. Protocolo de anemia de células falciformes o drepanocitosis de la Sociedad Española de Hematología Pediátrica (SEHP) 2002. Accesible en la página web: http://www.svnp. es/document/ protodrepanocitosis.htm
11. García M, Cantalejo MA, Cela ME, Bravo R, Galarón P, Beléndez C. Enfermedad de células falciformes: registro de la Sociedad Española de Hematología Pediátrica. An Pediatr. 2006;64: 78-84.
12. Lorey F, Cunningham G, Shafer F, Lubin B, Vichinsky E. Universal screening for haemoglobinopathies using high performance liquid chromatography: Clinical results of 2.2 million screens. Eur J Hum Genet. 1994;2:262-71.
13. Sickle Cell Disease Guideline Panel. Sickle cell disease: Screening, diagnosis, management and counselling in newborns and infants (Clinical practice Guideline 6.) Rockville MD: US Department of Health and Human Sciences, 1993.
14. Horn ME, Dick MC, Frost B, Davis LR, Bellingham AJ, Stroud CE, et al. Neonatal screening for sickle cell diseases in Camberwell: Results and recommendations of a two year pilot study. BMJ. 1986;292:737-40.
15. Harris MS, Eckman JR. Georgia's experience with newborn screening. Pediatrics. 1989;83:858-60.
16. Dulin E, Cantalejo MA, Cela ME, Galarón P. Detección precoz neonatal de anemia falciforme y otras hemoglobinopatías en la Comunidad Autónoma de Madrid. Estudio piloto. An Esp Pediatr. 2003;58:146-55.
17. Almeida AM, Henthorn JS, Davies SC. Neonatal screening for haemoglobinopathies: The results of a 10-year programme in an English Health Region. British J Haematology. 2001;112:32-5.
18. De Araujo MC, Serafim ES, De Castro WA Jr, De Medeiros TM. Prevalence of abnormal hemoglobins in newborns in Natal, Rio Grande do Norte, Brazil. Cadernos de Saude Publica. 2004;20:123-8.
19. Ducrocq R, Benkerrou M, Brahimi L, Belloy M, Briard ML, Vilmer E, et al. Neonatal screening for sickle cell anemia: Evaluation of a five year experience in an area of northern Paris. Arch Pediatr. 2001;8:474-80.
20. Lobo CL, Bueno LM, Moura P, Ogeda LL, Castillo S, De Carvalho SM. Neonatal screening for hemoglobinopathies in.Rio de Janeiro, Brazil. Pan Am J Public Health. 2003;13:154-9.
21. Heijboer H, Van den Tweel XW, Peters M, Knuist M, Prins J, Heymans HS. One year of neonatal screening for sickle-cell disease in Emma Children's Hospital/Academic Medical Center in Amsterdam. Nederlands Tijdschrift voor Geneeskunde. 2001;145:1795-9.
22. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ. 1995;311:1600-2.
23. Department of Health. Report of a working party of the Standing medical Advisory Committee on sickle cell, thalassaemia and other haemoglobinopathies. London: HMSO; 1993.
24. Neale MC, Neale BM, Sullivan PF. Nonpaternity in linkage studies of extremely discordant sib pairs. Am J Human Genetics. 2002;70:526-9.